Reevaluating the senolytic activity of a GLS1 inhibitor and an anti-PD-1 antibody: toward greater reproducibility and methodological rigor
Abstract The discovery of the senescence-associated secretory phenotype (SASP) has reshaped our understanding of cellular senescence, shifting its role from a solely tumor-suppressive mechanism to a potential driver of chronic inflammation and age-related diseases. Accordingly, senolytic drugs, whic...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Nature
2026-04-01
|
| Serier: | EMBO Reports |
| Fag: | |
| Online adgang: | https://doi.org/10.1038/s44319-026-00740-5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
